ALZHEIMER'S DISEASE(AD)
Clinical trials for ALZHEIMER'S DISEASE(AD) explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER'S DISEASE(AD) trials appear
Sign up with your email to follow new studies for ALZHEIMER'S DISEASE(AD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ABBV-916 aims to slow Alzheimer's in early stages
Disease control CompletedThis study tested an experimental drug called ABBV-916 in people with early Alzheimer's disease. Participants received either the drug or a placebo intravenously every 4 weeks for 6 months, with an optional 2-year extension where everyone gets the drug. The goal was to check safe…
Matched conditions: ALZHEIMER'S DISEASE(AD)
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can AI software sharpen Alzheimer's diagnosis?
Diagnosis CompletedThis study tested whether a computer program called SCALE PET helps doctors more accurately spot signs of Alzheimer's disease in brain scans. Researchers looked at 190 past scans from people with Alzheimer's or mild memory problems. Four doctors read the scans twice—once with the…
Matched conditions: ALZHEIMER'S DISEASE(AD)
Phase: NA • Sponsor: NEUROPHET • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
Simple blood test could spot Alzheimer's early
Diagnosis CompletedThis study tested a new blood test that uses a microfluidic chip to detect Alzheimer's disease. Researchers collected blood and urine samples from 150 people, including those with Alzheimer's, other brain diseases, and healthy volunteers. The goal was to see if the test could acc…
Matched conditions: ALZHEIMER'S DISEASE(AD)
Sponsor: Amoneta Diagnostics SAS • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Pink noise at night may boost memory in early Alzheimer's
Symptom relief CompletedThis study tested whether playing a gentle sound called 'pink noise' during deep sleep could strengthen memory in people with early Alzheimer's disease. Nineteen participants wore a special headband that delivered the noise on some nights and not on others. The goal was to see if…
Matched conditions: ALZHEIMER'S DISEASE(AD)
Phase: NA • Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a graphene cap boost brain health in seniors?
Symptom relief CompletedThis completed study tested whether wearing a special graphene cap that emits far-infrared heat could improve thinking and mood in older adults with mild cognitive decline or Alzheimer's. 126 participants were split into groups based on their cognitive level and received either t…
Matched conditions: ALZHEIMER'S DISEASE(AD)
Phase: NA • Sponsor: Institute of Psychology, Chinese Academy of Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Nerve block shows promise for Alzheimer's symptoms in small trial
Symptom relief CompletedThis study tested whether a procedure called a stellate ganglion block (SGB), given with standard medication, could improve thinking and memory in people with Alzheimer's disease. Forty participants were randomly assigned to receive either SGB plus standard drugs or standard drug…
Matched conditions: ALZHEIMER'S DISEASE(AD)
Phase: NA • Sponsor: Taizhou Second People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New pill for early Alzheimer's shows promise in small trial
Symptom relief CompletedThis Phase 2 study tested an experimental drug called ABBV-552 in 263 people with mild Alzheimer's disease. Participants took either the drug or a placebo daily for 12 weeks. The goal was to see if the drug could safely improve memory and thinking. The results will help decide if…
Matched conditions: ALZHEIMER'S DISEASE(AD)
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Massive Alzheimer's study aims to sharpen diagnosis and trial design
Knowledge-focused CompletedThis completed observational study enrolled 1,141 participants with mild cognitive impairment or Alzheimer's disease. Researchers tracked changes in memory tests, brain scans, and other biomarkers over time. The goal was to improve how future clinical trials measure the disease, …
Matched conditions: ALZHEIMER'S DISEASE(AD)
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC